Brind.

Helius sought authorization from the FDA on July 21, 2025, regarding a PoNS device originating from Newtown.

1 report, 1 independent Updated Jul 21

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Helius Newtown FDA

Keep exploring

The entities involved

Helius
Solana developer platform and infrastructure company

Nothing else this week.
Newtown
railway station in Pennsylvania, United States

Nothing else this week.
FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Coverage

Newest first; wire copies grouped

Jul 21GlobeNewswireHelius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation NEWTOWN, Pa., July 21, 2